Procuratio
Procuratio is a South Korean digital health company that provides the ProcareNote platform — combining AI-powered adverse event monitoring, web-based eCRF, IoT data capture, and clinical consulting — to CROs, pharmaceutical companies, and academic researchers conducting clinical trials.
- Company typePrivate
- Founded2018
- HeadquartersSongpadong, South Korea
- Headcount—
- GTM typeB2B
- OfferingSoftware
What Procuratio does
Procuratio (주식회사 프로큐라티오) is a South Korean digital health company founded in January 2018 by Professor Choi Chang-min of Seoul Asan Hospital, headquartered in Songpa-gu, Seoul. The company builds the ProcareNote platform, an integrated clinical trial software stack combining a web-based electronic Case Report Form (eCRF) system, an AI-powered adverse event (AE) monitoring mobile application with automatic grading, IoT device integration for patient lifelog and vital sign capture, and deep-learning analytics. The platform also encompasses healthcare consulting, real-world data and big-data analysis services, and a ring-type wearable oxygen saturation device for early pneumonia prediction. Underlying technology leverages multimodal AI (text, voice, image, video, structured clinical data) trained on proprietary Seoul Asan Hospital clinical data.
Procuratio's go-to-market is direct enterprise sales to CRO companies, pharmaceutical companies (with Yuhan Corporation as a strategic investor and reference), and university-hospital academic researchers conducting clinical trials, primarily in Korea with stated expansion plans into China and Vietnam. Revenue streams include subscription-based eCRF services priced on research scope and duration, professional services for clinical trial consulting, data analysis, and medical device distribution. The company also operates a molecular diagnostics subsidiary, Kade (established March 2022), and acquired MedicaLogic in January 2019 to absorb eCRF capabilities. The company has received multiple consecutive industry recognitions including 4IR Awards in the Bio-Health and Big Data sectors (2020-2022), Korea Innovation Awards (2020-2022), Inno-Biz AA certification, and the 2023 Donga Ilbo Medical Korea Award.
Revenue, headcount, and funding amounts are not publicly disclosed; the company is privately held with no parent company identified and no plans for an IPO. Its moat is anchored in the founder's clinical authority and exclusive hospital data access, with regulatory certifications and an integrated platform stack supporting differentiation in the Korean clinical trial IT market.
Procuratio firmographics
Firmographics- Name
- Procuratio
- Legal name
- 주식회사 프로큐라티오
- Website
- https://procuratio.kr
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Short description
- Procuratio is a South Korean digital health company that provides the ProcareNote platform — combining AI-powered adverse event monitoring, web-based eCRF, IoT data capture, and clinical consulting — to CROs, pharmaceutical companies, and academic researchers conducting clinical trials.
- Ownership category
- akta.pro rank
Procuratio industry classification
Industry- Product category
- Clinical Trial Management Software
- NAICS
- Other Scientific and Technical Consulting Services (54169), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
- akta.pro secondary industries
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where Procuratio is headquartered
LocationHeadquarters
- HQ city
- Songpadong
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
Procuratio business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- eCRF Solution Services: Web-based eCRF (electronic case report form) clinical research management system provided as a subscription/service model. Pricing is based on research characteristics, duration, and number of questions.
- Healthcare Consulting Services: Comprehensive consulting for successful clinical research including project management, IRB application guide, protocol work, research consultation, clinical trial service support, task management, medical drama, new drug development, medical device evaluation, clinical research, and big data analysis.
- ProcareNote AE Management Solution: Adverse event management solution for clinical trial participants, combining mobile app and AI prediction platform. Revenue derived from service provision to CRO companies and pharmaceutical companies.
- Data Analysis Services: Data mining of real-world data and healthcare big data, clinical data linkage and analysis, statistics provision, machine learning algorithm development support, and data conversion and transformation services.
- Medical Device Distribution and Consulting: Sourcing and commercialization of innovative medical devices and diagnostic products, including domestic clinical consulting, domestic/foreign market research, and distribution consulting with domestic and foreign network.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | eCRF service pricing based on research characteristics, duration, and number of questions |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
Procuratio product offering
Product offeringCore offering
Procuratio provides the ProcareNote platform, an integrated clinical research solution combining a web-based eCRF (electronic Case Report Form) system, an AI-powered adverse reaction (이상반응) automatic grading and real-time monitoring system, a mobile application for patient-reported outcomes, and IoT integration for clinical trial data collection. The platform enables CROs, pharmaceutical companies, and academic clinical researchers to conduct clinical trials with real-time 24/7 adverse event monitoring, early prediction of trial outcomes, and streamlined multi-site/multi-country data management.
Product overview
Procuratio operates as a unified clinical research platform under the ProcareNote brand, offering an integrated suite of clinical trial solutions organized by service letters (A through T). The core offering is the ProcareNote platform combining a web-based eCRF solution, AI-powered adverse reaction monitoring mobile app, IoT healthcare integration, and deep learning analytics. Supporting services include healthcare consulting, data analysis (RWD/big data mining), and medical device distribution. The company also owns diagnostic subsidiary Kade (established 2022) and acquired Medical Logic (2019) to expand capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- ProcareNote (프로케어노트): A comprehensive A-to-Z clinical research platform encompassing adverse event monitoring mobile app, AI-based automatic adverse event classification, eCRF (electronic case report form) solution, IoT healthcare, big data management, and deep learning-based healthcare services.
Products and services
- ProcareNote (프로케어노트) Comprehensive A-to-Z clinical research platform under which all clinical trial solutions are offered, including adverse reaction monitoring mobile app, AI-powered automatic detection, eCRF integration, IoT healthcare, big data management, and deep learning algorithms. Targeted at CROs, pharmaceutical companies, and academic researchers conducting clinical trials.
- ProcareNote eCRF Solution Web-based clinical research management system (electronic Case Report Form) that integrates and manages clinical trial data for smooth operation across diverse research environments. Features researcher-friendly interface, CIDSC standard structure, multi-site/multi-country support, randomization, automatic queries, calculation/logic functions, audit trail, DICOM medical image viewing, real-time statistics, and data export. For clinical researchers and trial sponsors.
- Healthcare Consulting Services (의료컨설팅) Comprehensive consulting for successful clinical trial execution including project management, IRB application guide, protocol work, research consultation, clinical trial service support, medical writing, new drug development consulting, and medical device evaluation. For pharmaceutical companies, CROs, and academic researchers.
- Data Analysis Services (데이타분석) Real-world data (RWD) and healthcare big data mining, clinical information integration and analysis, statistical services, machine learning algorithm development support, and large-scale data transformation. Includes healthcare big data open system integration. For pharmaceutical companies, CROs, and academic researchers.
- Medical Device Consulting and Distribution (의료기기) Sourcing and commercializing innovative medical devices and diagnostic products. Provides domestic clinical consulting, domestic and foreign market research, and distribution consulting with domestic and foreign network. Specializes in lung cancer diagnosis and treatment devices. For medical device manufacturers seeking market entry.
- AI Adverse Reaction Monitoring (인공지능 이상반응 자동판정) Artificial intelligence system for automatic adverse reaction grading and real-time alerts. Predicts clinical trial success probability by analyzing accumulated data. Part of the ProcareNote platform's three core technologies. For CROs and pharmaceutical companies.
- ProcareNote Mobile App Smartphone application for adverse reaction recording by clinical trial participants. Collects data via chatbot, voice, image, video, and IoT lifelog integration. Enables 24/7 patient monitoring with real-time notifications to clinical staff. For clinical trial participants.
- IoT Integration Service (IoT 연동 개발) IoT device integration development service for clinical research. Connects various IoT medical devices to the clinical trial platform, including patient vital sign monitoring systems and hospital patient transfer monitoring systems. For clinical researchers and trial sponsors.
- Ring-type Oxygen Saturation Measurement Device (반지형 산소포화도 측정기) Wearable ring device for measuring blood oxygen saturation. Smartphone app integration for easy access. Predicts pneumonia early based on vital signs, basic characteristics, underlying diseases, and medications. AI algorithm trained on data from 2,019 pneumonia patients and 9,137 control subjects with AUC accuracy of 0.9 or higher. For clinical trial participants and at-risk patients.
Quantifiable outcome
- Pneumonia early prediction algorithm achieved AUC accuracy of 0.9 or higher
- +2 more outcomes
Companies that use Procuratio
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Procuratio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability11 records
Feature5 records
Procuratio partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- 케이드 (KED)coreProcuratio established a diagnostic subsidiary called 케이드 (KED) in March 2022 to complement its diagnostic business. KED is a molecular diagnostics specialized company aimed at enhancing the diagnostic sector of Procuratio's operations.
- 딥노이드 (DeepNoid)coreDeepNoid and Procuratio entered into a joint business agreement for AI medical data analysis solution development. The partnership leverages DeepNoid's medical AI research platform 'DEEP:PHI' to develop e-CRF based AI solutions for clinical data analysis. Initial focus is on lung cancer patient medical image and clinical data analysis (risk factors, tissue biopsy results, treatment and anticancer drug response), with plans to expand to various disease AI diagnostic and treatment evaluation solutions. The partnership combines Procuratio's clinical data platform expertise with DeepNoid's imaging platform capabilities.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Procuratio competitors and assessment
Company assessmentDirect peers
- Clario: Generates clinical evidence via eCOA, imaging, and wearables for clinical trials, including adverse event data capture. Directly comparable to Procuratio's mobile app + IoT lifelog + AI AE grading combination.
- Medrio: EDC, ePRO, and eConsent platform for clinical trials, with emphasis on mid-sized sponsors and academic researchers. Comparable to Procuratio's subscription-based eCRF pricing model and academic researcher customer segment.
- Signant Health: Specialist in eCOA, ePRO, and patient-centric clinical trial technology. Closely comparable to Procuratio's ProcareNote mobile AE capture and AI grading roadmap, and competes for the same pharma/CRO budget line item.
- Castor: Cloud-based EDC platform with modular ePRO and remote patient monitoring capabilities serving academic and commercial sponsors. Comparable to Procuratio's web-based eCRF for academic clinical researchers and CROs, with similar self-service deployment model.
Broad incumbents
- Medidata Solutions (Dassault Systèmes): Industry-leading EDC and clinical trial technology platform (Rave EDC, eCOA) used by most large pharmaceutical sponsors and CROs. Comparable because Procuratio's eCRF + AE-AI + eCOA stack targets the same buyer segments with overlapping core functionality, though Medidata is much broader and more established.
- IQVIA (Clinical Technology): Largest CRO with bundled clinical trial technology (EDC, eCOA, CTMS) and proprietary data assets. Competes with Procuratio for pharma AE monitoring and clinical data management spend, though Procuratio positions against its IT-based monitoring personnel reduction pain point.
- Oracle Clinical One: Oracle's unified clinical trial platform (inherited from Phase Forward) covering EDC, randomization, and trial design. Competes with Procuratio's eCRF solution for enterprise pharma customers, though at much larger scale.
- Veeva Systems (Vault CDMS / Vault EDC): Provides Vault EDC and CTMS as part of its life sciences cloud suite, serving pharma and CRO buyers with integrated clinical data management. Directly comparable technology stack (EDC/CTMS for clinical trials) targeting the same enterprise pharma and CRO customer base.
Emerging players
- OpenClinica: Open-source / cloud EDC platform serving academic and mid-tier sponsors. Comparable eCRF functionality and similar mid-tier enterprise customer focus as Procuratio's academic researcher and CRO segments.
Others
- Deepnoid: Korean medical AI company with the DEEP:PHI imaging platform. Partner of Procuratio for AI medical data analysis and adjacent in lung cancer imaging AI — useful as a comparable for the company's AI capability roadmap rather than a direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Procuratio compliance and trust
Trust signalCompliance5 records
Procuratio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Procuratio leadership team
Management profileNumber of profiles
Profiles4 records
Procuratio subsidiaries and ownership
Company hierarchySubsidiaries2 records
Procuratio funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Procuratio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Procuratio
What does Procuratio do?
Procuratio provides the ProcareNote platform, an integrated clinical research solution combining a web-based eCRF (electronic Case Report Form) system, an AI-powered adverse reaction (이상반응) automatic grading and real-time monitoring system, a mobile application for patient-reported outcomes, and IoT integration for clinical trial data collection. The platform enables CROs, pharmaceutical companies, and academic clinical researchers to conduct clinical trials with real-time 24/7 adverse event monitoring, early prediction of trial outcomes, and streamlined multi-site/multi-country data management.
Is Procuratio a public or private company?
Procuratio is a private company. It is classified as venture growth investor backed and is currently operating.
When was Procuratio founded?
Procuratio was founded in 2018.
Where is Procuratio based?
Procuratio is headquartered in Songpadong, South Korea, in the Asia region.
How does Procuratio make money?
Five revenue lines are on record. eCRF Solution Services are the primary driver. The others are healthcare Consulting Services, procareNote AE Management Solution, data Analysis Services and medical Device Distribution and Consulting.
Who are Procuratio's main competitors?
Direct peers on record are Clario, Medrio, Signant Health and Castor. Broad incumbents are Medidata Solutions (Dassault Systèmes), IQVIA (Clinical Technology), Oracle Clinical One and Veeva Systems (Vault CDMS / Vault EDC). OpenClinica is listed as an emerging player. Deepnoid is listed as an others.
Does Procuratio have an API?
No public API is recorded for Procuratio.
What industry is Procuratio in?
Procuratio's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 54169 and its SIC code is 7372.